Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...
FOX 13's Allie Corey sat down with the chief of surgical oncology at TGH Institute and professor of surgery at USF Health as ...
Investigators concluded that the encouraging oncologic outcomes coupled with a favorable safety profile warrant further ...
A study published in the November issue of Redox Biology has found that adding intravenous, high-dose vitamin C to a ...
Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields ...
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers, with a survival rate of just 11%. A primary culprit ...
There's no routine screening test for pancreatic cancer, and symptoms can be mistaken for common illnesses.
A US Navy veteran who one day began having severe chest and back pain was diagnosed with stage 2 pancreatic cancer—one of the deadliest. According to doctors, the symptoms she had were completely ...
Novocure’s positive phase 3 results boost pancreatic cancer treatment prospects. Read why NVCR stock is worth watching with ...
Dec 2 (Reuters) - Novocure (NVCR.O), opens new tab said on Monday its experimental therapy extended the lives of patients with a form of advanced pancreatic cancer when combined with chemotherapy ...
This morning, dealing with it after it develops and becomes a real threat. One key treatment option is called the Whipple ...
NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.